HY-147237-50mg
|
MedChemexpress LLC
|
LpxC-IN-10 [CAS 2413574-64-6]
|
|
COVID-19-immunoregulation
|
|
HY-108944-10mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
HY-108944-100mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
HY-108944-25mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
HY-108944-5mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
HY-108944-50mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
HY-101603-1mg
|
MedChemexpress LLC
|
ManitiMu s [CAS 202057-76-9]
|
|
COVID-19-immunoregulation
|
|
HY-101603-10mg
|
MedChemexpress LLC
|
ManitiMu s [CAS 202057-76-9]
|
|
COVID-19-immunoregulation
|
|
HY-101603-20mg
|
MedChemexpress LLC
|
ManitiMu s [CAS 202057-76-9]
|
|
COVID-19-immunoregulation
|
|
HY-101603-5mg
|
MedChemexpress LLC
|
ManitiMu s [CAS 202057-76-9]
|
|
COVID-19-immunoregulation
|
|
HY-101603-1mL
|
MedChemexpress LLC
|
ManitiMu s [CAS 202057-76-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-107648-10mg
|
MedChemexpress LLC
|
McN-A-343 [CAS 55-45-8]
|
|
COVID-19-immunoregulation
|
|
HY-107648-100mg
|
MedChemexpress LLC
|
McN-A-343 [CAS 55-45-8]
|
|
COVID-19-immunoregulation
|
|
HY-107648-25mg
|
MedChemexpress LLC
|
McN-A-343 [CAS 55-45-8]
|
|
COVID-19-immunoregulation
|
|
HY-107648-5mg
|
MedChemexpress LLC
|
McN-A-343 [CAS 55-45-8]
|
|
COVID-19-immunoregulation
|
|
HY-107648-50mg
|
MedChemexpress LLC
|
McN-A-343 [CAS 55-45-8]
|
|
COVID-19-immunoregulation
|
|
HY-115374-100mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-250mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-50mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|